GSK and Dundee to find new drugs for tropical diseases with Wellcome Trust funding
This article was originally published in Scrip
Executive Summary
The development of new drugs for neglected tropical diseases is the subject of the latest agreement between GlaxoSmithKline and the University of Dundee. The partnership will focus on a series of preclinical compounds for leishmaniasis, Chagas' disease and African sleeping sickness, supported by a grant of £8.6 million from the Wellcome Trust.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.